KKodak provides imaging solutions and specialty materials for business customers in electronics, textiles, healthcare, and industrial manufacturing. Its products include silver films and processing chemicals for electronics, direct-to-garment inks, solvent recovery systems, large-format aerial films, industrial X-ray films, specialty chemicals, antimicrobial materials, and thin-film coatings, which are used in imaging, coating, printing, testing, and recycling processes. Kodak differentiates itself with a long history in imaging and materials science, a broad portfolio, and licensing of technology, all served through a global B2B network. The goal is to help customers produce high-quality, reliable imaging and material solutions at scale.
Work here?Claim your company
Industries
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Rochester, NY
Founded
1892
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$1.1B
Above
Industry Average
Funded Over
5 Rounds
Eastman Kodak Company expands Kodak pharmaceuticals portfolio with launch of Kodak Normal Saline 0.9%. Published on 10/28/2026 at 02:50 pm EDT S&P Capital IQ Eastman Kodak Company announced the expansion of its KODAK PHARMACEUTICALS portfolio with the addition of KODAK Normal Saline, 0.9%. KODAK PHARMACEUTICALS sterile solutions are now available for convenient online ordering in the U.S. This product addition builds on Kodak?s growing portfolio of sterile, ready-to-use buffers and reagents manufactured in its U.S.-based, FDA-registered cGMP facility. KODAK Normal Saline, 0.9% expands Kodak?s portfolio into sterile reagents for laboratory and bioprocessing workflows. Manufactured and aseptically filled in the United States, the isotonic solution is fully traceable and USP-compliant where applicable. It supports Kodak?s strategy to provide customers in regulated environments with consistent quality, transparent sourcing and a more reliable domestic supply. The addition of KODAK Normal Saline, 0.9% marks the next step in Kodak?s phased expansion of its pharmaceutical portfolio, which includes Water for Injection and multiple PBS formulations, with additional products planned. Kodak is also progressing toward the introduction of Class II products as part of its broader strategy to expand its portfolio and support customers with reliable, domestically produced pharmaceutical solutions. (C) S&P Capital IQ - 2026
Kodak expands pharmaceutical portfolio with Normal Saline launch, debuts U.S. online store. This product addition builds on Kodak's growing portfolio of sterile, ready-to-use buffers and reagents manufactured in its U.S.-based, FDA-registered cGMP facility. October 28, 2026. 1:37 PM ROCHESTER, N.Y. - Eastman Kodak Co. is broadening its KODAK PHARMACEUTICALS business with the introduction of KODAK Normal Saline, 0.9%, and the launch of a new U.S.-based e-commerce platform designed to streamline purchasing for pharmaceutical, biotechnology and life sciences customers. The sterile isotonic saline solution expands Kodak's portfolio of ready-to-use buffers and reagents manufactured at the company's FDA-registered, current Good Manufacturing Practice (cGMP) facility in the United States. The product marks Kodak's entry into the sterile reagents market for laboratory and bioprocessing applications and is produced and aseptically filled domestically, with full traceability and USP compliance where applicable. Kodak said the launch supports its strategy of providing customers operating in regulated environments with high-quality products backed by transparent sourcing and a reliable U.S.-based supply chain. Alongside the product debut, Kodak unveiled a dedicated online marketplace for U.S. customers at pharmastore.kodak.com, offering direct access to its pharmaceutical-grade product portfolio. The platform enables users to browse products, compare specifications, view technical documentation and place orders online. "The launch of KODAK Normal Saline, 0.9% and our new U.S. online store reflect our commitment to making essential pharmaceutical products more accessible to customers," said Jim Continenza, executive chairman and CEO of Kodak. "By combining high-quality, domestically produced solutions with a simpler way to purchase them, we are creating a stronger foundation to serve pharmaceutical, biotech and life science organizations." The new saline product builds on Kodak's existing offerings, which include Water for Injection and several phosphate-buffered saline (PBS) formulations. The company said additional products are in development as it continues expanding its pharmaceutical business, including plans to introduce Class II products manufactured in the United States.
Virtual panel discussions. The AIA commemorative plaque is now open to the public during regular operating hours at the RMSC Strasenburgh Planetarium. (Photo provided by RMSC) AIAA recognizes Kodak's legacy in aerospace and space exploration. Five former and current Kodak facilities across the Rochester area have been designated an AIAA Historic Aerospace Site, recognizing the region's contributions to satellite imagery, lunar mapping and major NASA space missions. The American Institute of Aeronautics and Astronautics, the world's largest aerospace technical society, formally dedicated the sites under the designation "Rochester: Kodak's Aerospace Legacy." The recognition highlights the photographic, optical and engineering innovations developed at the facilities, many of which supported classified government programs and landmark space exploration efforts. "For more than half a century the people of Rochester quietly built the cameras, films and optics that let humanity see the Earth, the Moon and the distant universe," said Walter Gordon, chairman of the AIAA Niagara Frontier Section. The designation honors generations of engineers, scientists and technicians whose work often remained secret for decades, Gordon said. The five designated sites are Kodak Park, the Hawkeye Plant, the Lincoln Plant, Building 601 and the Elmgrove Plant. Kodak Park served as a research and manufacturing hub for photographic materials. The facility produced more than 1,500 miles of high-resolution film for classified National Reconnaissance Office programs, as well as specialized film for NASA's Apollo Lunar Orbiter program. The Hawkeye Plant housed the Bridgehead precision laboratory, where film from Corona, Gambit and Hexagon satellite cameras was processed around the clock. The Lincoln Plant, a government-owned facility, supported Gambit satellite research and development, parts manufacturing and final assembly. It also produced five camera and processor systems for NASA's Lunar Orbiter program, which mapped 99% of the lunar surface. Building 601 manufactured large optical components, including the telescope for NASA's Chandra X-ray Observatory, and provided critical support for the James Webb Space Telescope. It also delivered telescopes for the Nancy Grace Roman Space Telescope program in 2024. The Elmgrove Plant served as headquarters for Kodak's apparatus division and was a center for research, development and engineering of aerial photography equipment. The commemorative plaque is on public display at the Rochester Museum & Science Center's Strasenburgh Planetarium, where it can be viewed during regular operating hours. "The Strasenburgh Planetarium has always been a place where our community looks up at the cosmos in awe," said Jim Bader, director of the RMSC Strasenburgh Planetarium. "We are honored to house this historic plaque, celebrating how Rochester's groundbreaking optical innovations helped unlock the mysteries of space."
News from Kodak: new Kodak sustainability report highlights continued progress. Press play to listen to this content Rochester, N.Y., October 21, 2026 - Golden Business Forms, a state-of-the-art business forms printer based in Golden City, Missouri, has invested in a KODAK TRENDSETTER Q400 SA Platesetter and KODAK SONORA Process Free Plates in a move that will see the company switch to process free platemaking. Established in 1963, Golden Business Forms operates from a 70,000 square foot facility where it produces ATM rolls and fanfold receipts, continuous and cut sheet forms, and thermochecks. Selling exclusively to independent distributors, print brokers and agencies, the company relies on having the latest offset presses, roll conversion and platemaking technology to get every job done right the first time and shipped on schedule. Going process free increases prepress productivity and maintains quality Golden Business Forms replaced its 15-year-old ECRM Mako 800 CTP system with a KODAK TRENDSETTER Q400 Platesetter and switched to SONORA Process Free Plates. Producing 30 plates per hour - twice the previous throughput - the process-free solution streamlines prepress by eliminating chemicals, plate processing and related inventory tasks. Speaking only a week after the installation was completed, David Hieber, Prepress Lead at Golden Business Forms, commented: "You had me at 'process-free', with the speed of the TRENDSETTER Q400 and the quality of SONORA plates the benefits have been huge. Undoubtedly, the speed of the machine alone is much more than we ever envisioned, and so far our on-press experience is also going very well, if not excellent. The integration into our workflow has been flawless, for which we are extremely grateful," he added. That integration process was crucial to the success of the migration from the company's original platemaking process and was also fundamental to Golden Business Form's decision to choose Kodak to help it future proof its platemaking. The company operates round the clock with day and night production shifts, so careful planning and adequate on-site support were vital to ensuring the change would not impact its pressroom production schedule. Built on proven KODAK SQUARESPOT Imaging Technology, the 4-page TRENDSETTER Q400 combines stable, precise imaging with streamlined automation. Eliminating the processor saves around two minutes per plate - approximately 2.25 hours for 65 plates and more than 24 hours per month. Together with SONORA Process Free Plates, it also reduces errors, remakes, energy, water, chemistry and maintenance, lowering costs and supporting sustainability goals. "Golden Business Forms is deservedly proud of its track record for reliability and service, so it was vital to them that the migration from their original platemaking process to process free would not impact on their production schedule," commented Jeff Zellmer, Vice President Americas Sales, Kodak. "We're delighted that the combination of Kodak products, technical expertise and on-site resources has been able to not just deliver that transition successfully, but to exceed expectations." (C) Kodak, 2026. KODAK, TRENDSETTER, SONORA, and SQUARESPOT are trademarks of Eastman Kodak Company. About Kodak Kodak (NYSE: KODK) is a leading global manufacturer focused on commercial print and advanced materials & chemicals. With 79,000 worldwide patents earned over 130 years of R&D, Industry Analysts, Inc. believe in the power of technology and science to enhance what the world sees and creates. Its innovative, award-winning products, combined with its customer-first approach, make Industry Analysts, Inc. the partner of choice for commercial printers worldwide. Kodak is committed to environmental stewardship, including industry leadership in developing sustainable solutions for print. For additional information on Kodak, visit Industry Analysts, Inc. at Kodak.com or follow Industry Analysts, Inc. on LinkedIn Kodak Print. SOURCE Kodak
Kodak built the first digital camera: what Kodak is worth today. Kodak, the company whose engineer built the first digital camera, had a market value of about $874 million as of October 19, 2026. That is down about 97% from about $31 billion at its 1997 high, both values computed in nominal dollars. The camera came first. IEEE Spectrum reports that Kodak engineer Steven Sasson took the first photo with the first digital camera in December 1975. The prototype made images of 100 by 100 pixels, took 50 milliseconds to capture each one and 23 seconds to save it to tape. Kodak filed a patent on the electronic still camera on May 20, 1977, and US Patent 4,131,919 was granted to Eastman Kodak on December 26, 1978. For the next two decades, film paid the bills. Kodak reported sales of $14.98 billion in 1995, $15.97 billion in 1996 and $14.54 billion in 1997, and it had about 94,800 employees at the end of 1996. Its 1997 10-K says worldwide film sales held level that year on 7% higher volume. The two market values come from the same simple calculation: share price times shares outstanding. The 1997 figure uses the first-quarter 1997 stock high from Kodak's 1997 10-K and the 331.8 million shares outstanding at the end of 1996. Today's figure uses the KODK closing price on Nasdaq on October 19, 2026 and the 97.9 million shares Kodak reported on July 29, 2026. Neither is adjusted for inflation. A common version of the story says Kodak stayed with film while the world moved on. Kodak's own filings tell a different story. Its 2007 10-K says that in 2006, for the first time in its history, more than half of Kodak's revenue came from digital products. The pressure came from film itself: sales of the Film Products Group fell from $2.84 billion in 2005 to $2.31 billion in 2006 and $1.97 billion in 2007, a computed drop of about 31% in two years. Kodak's 10-K put it plainly: digital substitution has led to substantial declines in film usage. The losses followed. As reported in the 2012 10-K, Kodak's net loss was $0.44 billion in 2008, $0.21 billion in 2009, $0.69 billion in 2010, $0.76 billion in 2011 and $1.38 billion in 2012, about $3.5 billion in five years. On January 19, 2012, Kodak and its US subsidiaries filed for chapter 11 bankruptcy protection, a court-supervised reorganization rather than a shutdown. Weeks later, on February 9, 2012, it announced it would stop making its own digital cameras. Kodak emerged from chapter 11 on September 3, 2013, and all of its previously issued shares were cancelled. That detail matters for anyone comparing prices across eras. The KODK shares that trade today are a new stock, so an old share price and a new share price do not measure the same thing. Market value, the whole company at each date, is the comparison that holds up. Kodak still operates, at a much smaller size. Its 2025 10-K describes a global manufacturer focused on commercial print and advanced materials and chemicals. It reported $1.07 billion in 2025 revenue, 67% of it from print, and about 3,500 employees, against about 26,900 in 2007 and about 17,100 in 2011. It still makes film for still photography and for motion pictures. Building a new technology early and earning a living from it are separate problems. When the product that carries a company's sales shrinks faster than the new one can replace it, revenue, profits and market value can all fall at once, even after the shift has started. Watch the short video: YouTube Sources. Every figure above is drawn from real, dated public disclosures and links back to its source. See about and how stocks-llm work for how this is built, or get the iOS app. Informational only - NOT financial advice.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Rochester, NY
Founded
1892
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs